Article
Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells.
International journal of oncology - 1 Apr 2009
Song Ju Han, Kim Seung Hyun, Kweon Sin Ho, Lee Tae Hyang, Kim Hee-Je, Kim Hyeoung-Joon, Kim Tae Sung
Abstract excerpt
Resistance to cytarabine (Ara-C) incapacitates the therapeutic effort during the treatment of acute myeloid leukemia (AML). To elucidate mechanism responsible for the development of resistance to Ara-C, we established the Ara-C resistant AML-2/WT cell sublines, AML-2/IDAC and AML-2/ARC. We then conducted DNA microarray analysis to compare the AML-2/IDAC cells with parental AML-2/WT cells. The results of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
